 |
 |

Intratympanic Steroid Perfusion for Sudden Sensorineural Hearing Loss
Arch Otolaryngol Head Neck Surg. 2005;131:730-732.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Hypothesis: While the traditional treatment for idiopathic, sudden, sensorineural hearing loss (SNHL) is oral steroid therapy (and some argue that no other treatment is needed), intratympanic (IT) steroid therapy also has a role in treating this condition.
A MEDLINE literature search was performed for the years 1980 to 2004. The search strategy included the terms idiopathic hearing loss, sudden hearing loss, sudden sensorineural hearing loss, and steroids. Appropriate articles were selected and reviewed. Only articles published in English were included. Those articles addressing primarily idiopathic sudden SNHL and oral or IT steroid therapy as the preferred means of treatment were included in this analysis.
Figure appears in full text version.
|
|
|
|
|
BACKGROUND
Sudden SNHL is relatively common, affecting 5 to 20 individuals per 100 000. It is defined as a sudden hearing loss in 3 contiguous frequencies greater than 30 dB occurring within a 3-day period.1-2 While some drugs (eg, aminogycosides . . . [Full Text of this Article]
PRO
CON
BOTTOM LINE
AUTHOR INFORMATION
Sam J. Marzo, MD
Author Affiliations: Department of OtolaryngologyHead and Neck Surgery, Loyola University Health System, Maywood, Ill.
RELATED ARTICLES
Diagnostic and Management Dilemma of Sudden Hearing Loss
Aristides Sismanis
Arch Otolaryngol Head Neck Surg. 2005;131(8):733-734.
EXTRACT
| FULL TEXT
Broadening the Spectrum of Treatment Options for SNHL
Hinrich Staecker
Arch Otolaryngol Head Neck Surg. 2005;131(8):734.
EXTRACT
| FULL TEXT
|